Michael Wieland, PA
Physician Assistant · Moline, ILNPI 1861019945
Payments from drug & device makers
Across 237 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$668
- Dexcom, Inc.$501
- Novo Nordisk$465
- AstraZeneca$442
- Lilly USA, LLC$394
- Sanofi-aventis U.S. LLC$383
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,42599%
- Gifts$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 34 | $668 |
| Dexcom, Inc. | 19 | $501 |
| Novo Nordisk | 32 | $465 |
| AstraZeneca(2 entities) | 16 | $442 |
| Lilly USA, LLC | 26 | $394 |
| Sanofi-aventis U.S. LLC | 23 | $383 |
| AbbVie | 10 | $160 |
| Medtronic | 8 | $158 |
| Xeris Pharmaceuticals, Inc. | 8 | $140 |
| Bayer | 7 | $136 |
| Antares Pharma, Inc. | 9 | $134 |
| Mannkind Corporation | 4 | $117 |
| Corcept Therapeutics | 5 | $109 |
| Novartis | 4 | $72 |
| Merck | 4 | $60 |
| Bigfoot Biomedical Inc | 3 | $58 |
| Abbott | 3 | $56 |
| Tandem Diabetes Care, Inc. | 2 | $48 |
| Sequel Med Tech, LLC | 2 | $47 |
| Boehringer Ingelheim | 3 | $47 |
| Almatica Pharma LLC | 2 | $44 |
| Insulet Corporation | 2 | $36 |
| Amryt Pharma Holdings Ltd | 2 | $34 |
| Averitas Pharma Inc. | 1 | $29 |
| Ascensia Diabetes Care US Inc. | 1 | $28 |
| Sandoz | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Ascendis Pharma Endocrinology Inc | 1 | $16 |
| Halozyme Inc | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
| Radius Health, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G6 TRANSMITTER$244
- FARXIGA$159
How this compares
$4,484 in reported general payments places this provider in the 90th percentile of 3,912 physician assistant providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 289 | $579,022 |
| TrulicityDulaglutide | 147 | $216,027 |
| JardianceEmpagliflozin | 157 | $209,352 |
| Tresiba Flextouch U-100Insulin Degludec | 110 | $123,162 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 38 | $76,428 |
| Humalog Kwikpen U-100Insulin Lispro | 99 | $52,907 |
| MounjaroTirzepatide | 26 | $43,991 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 199 | $43,827 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 38 | $41,997 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $39,608 |
| FarxigaDapagliflozin Propanediol | 20 | $30,199 |
| Novolog FlexpenInsulin Aspart | 74 | $29,295 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 66 | $29,029 |
| JanuviaSitagliptin Phosphate | 14 | $19,556 |
| TradjentaLinagliptin | 15 | $18,652 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $465 | $582,757305 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $394 | $275,962213 claims |
| Boehringer IngelheimJardiance, Tradjenta | $47 | $228,004172 claims |
| AstraZenecaFarxiga | $442 | $30,19920 claims |
| MerckJanuvia | $60 | $19,55614 claims |
| Sanofi-aventis U.S. LLCLantus | $383 | $4,11128 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,912 physician assistant providers in Illinois.
Other physician assistant in Moline
- Andrew MastroChicago$419K
- Christopher AricoSkokie$407K
- Karlijn BurridgeWestmont$144K
- Ian MackeySkokie$135K
- Stephanie TraceyItasca$122K
- Olabimpe PhilipsAddison$103K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
- Christina StarksChicago$77K
- Darrel CutlerHerrin$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.